Trial Profile
Phase II Study of Eloxatin + 5-Fluorouracil/Leucovorin in Patients With Unresectable Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Liver cancer
- Focus Therapeutic Use
- Sponsors Sanofi
- 10 Feb 2006 New trial record.